Politics

Pandemic waivers made it easier to get treatment for opioid addiction. That could all go away next month.

Waivers on telehealth restrictions have opened the door to a previously unattainable type of care for people with opioid use disorder. Will they stick?

Pandemic waivers made it easier to get treatment for opioid addiction. That could all go away next month.

The COVID-19 pandemic has enabled startups that treat people with opioid use disorder to go totally virtual. That could change.

Photo: Craig F. Walker/The Boston Globe via Getty Images

In the early months of 2020, Stephanie Strong had modest ambitions for her startup, Boulder Care, a telehealth company that treats people who are addicted to opioids. The company had begun seeing patients in October 2019, and, this year, if all went according to plan, Strong expected that Boulder would have a limited number of patients in Alaska, where the company had just struck a deal with Premera, the largest insurer in the Pacific Northwest.

This year, all has not gone according to plan. When the COVID-19 pandemic hit, the telehealth market exploded, thanks to a combination of stay-at-home orders and regulatory waivers that instantly boosted mainstream providers like Teladoc and Doctor on Demand. But for Boulder and the small cohort of startups like it, the public health emergency did more than just bring in more business. It opened the door to a previously unattainable type of care for people with opioid addiction that advocates and health care professionals have been championing for years.

Boulder treats patients through a combination of coaching and a drug called buprenorphine. In normal times, the law requires doctors to get preauthorized and meet with their patients in person before they can prescribe it. Strong and others argue those obstacles prevent people from getting care at the moment they need it, particularly in places where there aren't many authorized physicians. "That critical moment where someone is really ready for care, that's where we want to create that onramp," Strong said.

But when COVID-19 hit, the government lifted the in-person visit requirement, meaning that now, Boulder can onboard patients fully remotely. The switch changed Boulder's entire growth trajectory, enabling it to expand beyond a corner of the Alaskan market to all of Alaska, Oregon and Washington.

Ophelia, a similar, Philadelphia-based startup that offers what's known as medication-assisted treatment for opioid use disorder, also felt a boost: It launched in April and is already seeing 130 patients across Pennsylvania and New York. "You have a huge population of people living in rural America who don't have access to treatment at all, and we wouldn't have been able to treat them without the regulatory changes," said Zack Gray, Ophelia's co-founder and CEO. "We would have had to be set up in urban hubs, which would have likely been Philadelphia or Pittsburgh, but definitely not Pottsville."

But the strides the industry has made these last five months may not last. The federal public health emergency declaration that gave rise to these changes is set to expire in late October. Barring an extension, the telehealth waivers could expire along with it. Now, virtual care companies, advocacy groups and even some lawmakers are using this moment to amplify the call to make these changes permanent. "The need for this access to care was evidenced even prior to the pandemic. The pandemic just made it all the more urgent," said Libby Baney, a partner specializing in digital health at the law firm Faegre Drinker and a senior adviser to The Alliance for Safe Online Pharmacies. "Now, the question is: Do we go back?"

The restrictions on telehealth services for medication-assisted treatment date back to 2008, when Congress passed the Ryan Haight Act, named for an 18-year-old who died of an overdose after buying Vicodin online. That law established the in-person visit requirement for controlled substances but gave the Drug Enforcement Administration the authority to create a special registration for telemedicine providers.

More than a decade later, the DEA has yet to create such a process. In the meantime, the telehealth industry has grown dramatically — as has the opioid crisis, which kills about 70,000 Americans a year. "These laws were made before the age of telehealth," Gray said. "They just haven't evolved."

The DEA isn't the only one with the power to change the status quo. In Congress, Republican Sen. Rob Portman and Democratic Sen. Sheldon Whitehouse have put forward a bipartisan bill called the TREATS Act, which would make the waivers on in-person visits for medication-assisted treatment permanent. "As we move forward and look to life beyond this pandemic, we must make sure that the advances to care and access that telehealth is currently providing is not lost, and that's exactly what this bill will do," Portman said in a statement when the bill was introduced in June.

That bill has received the backing of a broad coalition of health care organizations, including the American Psychiatric Association and the American Society of Addiction Medicine, among others. "Without the swift passage of the TREATS Act, the Trump administration's actions to waive certain telehealth-related restrictions due to COVID-19 may soon expire," the Coalition to Stop Opioid Overdose wrote in a July letter to the leaders of the House and Senate. "If Congress were to let that happen, then patients could experience an abrupt and needless disruption in the delivery of lifesaving addiction care through telehealth."

The TREATS Act has yet to go anywhere in Congress. Even if it did, there would still be state laws and procedures to contend with. That is where Boulder has been spending a lot of its time. Despite federal regulatory waivers, some states still have onerous, conflicting policies on the books regarding virtual care. In the early days of the pandemic in Alaska, Boulder found that despite the federal waivers, local laws were still preventing people in the state from getting onboarded virtually. "I had a woman call from a remote part of Alaska, and we could not see her, because we had to have that in-person visit prior to her engaging in our treatment," said Kara Nelson, Boulder's supervisor of peer coaching.

Nelson, who, like all of Boulder's peer coaches, is in recovery herself, testified before Alaska's Medical Board in favor of lifting in-person visit requirements during COVID-19, which the board eventually did. In Oregon, meanwhile, Boulder has successfully petitioned the Health Authority to intervene in a case where a patient's insurer was denying coverage of her medication.

"We know where these regulations came from, but it's time to revisit them and annihilate those barriers," Nelson said.

There is, of course, a reason these laws exist, including at the federal level. There are plenty of bad actors on the internet eager to push pills to strangers without any oversight. But defenders of virtual care say that the bad guys are doing that already, both online and off. If anything, tracking that bad behavior may be easier in a world where everything is digitized, says Andrey Ostrovsky, former chief medical officer for the Centers for Medicaid and Medicare Services and a current Boulder investor. "We need to make sure, just like brick and mortar, that there isn't garbage care being provided," Ostrovsky said. "With virtual care, we have much more digital exhaust to use for fraud detection and quality measurement than we do for brick and mortar services."

The question isn't whether making these waivers permanent for telemedicine providers would lead to abuse. It's whether it would lead to more abuse than previously existed — and whether that abuse would outweigh the benefits to patients. For a long time, it was impossible to know the answer to that question. But these last few months, as companies like Ophelia and Boulder have operated without some of those restrictions, it's created something of a natural experiment. Baney calls it "a pandemic pilot program" and says it should guide the decisions regulators and lawmakers make about how to proceed.

"We did waive those rules. We created access channels. Companies were able to come in and serve patients legitimately through telehealth," Baney said. "What did the data show?"

For now, at least, the data shows that telehealth hasn't been a cure-all for the opioid crisis. According to the American Medical Association, more than 40 states have reported an increase in opioid-related mortality since the onset of the COVID-19 pandemic. That's far from a condemnation of telehealth, though. Quite the opposite. In response to those reports, the AMA is now urging governors across the country to adopt the federal flexibility around telemedicine as a way to deal with the uptick in overdoses.

There's still time for the government to extend the current waivers. If it doesn't, it will mean that Boulder and Ophelia and other companies like them will have to go back to the old way of operating, serving fewer patients at the very moment when so many more need help.

Fintech

Judge Zia Faruqui is trying to teach you crypto, one ‘SNL’ reference at a time

His decisions on major cryptocurrency cases have quoted "The Big Lebowski," "SNL," and "Dr. Strangelove." That’s because he wants you — yes, you — to read them.

The ways Zia Faruqui (right) has weighed on cases that have come before him can give lawyers clues as to what legal frameworks will pass muster.

Photo: Carolyn Van Houten/The Washington Post via Getty Images

“Cryptocurrency and related software analytics tools are ‘The wave of the future, Dude. One hundred percent electronic.’”

That’s not a quote from "The Big Lebowski" — at least, not directly. It’s a quote from a Washington, D.C., district court memorandum opinion on the role cryptocurrency analytics tools can play in government investigations. The author is Magistrate Judge Zia Faruqui.

Keep Reading Show less
Veronica Irwin

Veronica Irwin (@vronirwin) is a San Francisco-based reporter at Protocol covering fintech. Previously she was at the San Francisco Examiner, covering tech from a hyper-local angle. Before that, her byline was featured in SF Weekly, The Nation, Techworker, Ms. Magazine and The Frisc.

The financial technology transformation is driving competition, creating consumer choice, and shaping the future of finance. Hear from seven fintech leaders who are reshaping the future of finance, and join the inaugural Financial Technology Association Fintech Summit to learn more.

Keep Reading Show less
FTA
The Financial Technology Association (FTA) represents industry leaders shaping the future of finance. We champion the power of technology-centered financial services and advocate for the modernization of financial regulation to support inclusion and responsible innovation.
Enterprise

AWS CEO: The cloud isn’t just about technology

As AWS preps for its annual re:Invent conference, Adam Selipsky talks product strategy, support for hybrid environments, and the value of the cloud in uncertain economic times.

Photo: Noah Berger/Getty Images for Amazon Web Services

AWS is gearing up for re:Invent, its annual cloud computing conference where announcements this year are expected to focus on its end-to-end data strategy and delivering new industry-specific services.

It will be the second re:Invent with CEO Adam Selipsky as leader of the industry’s largest cloud provider after his return last year to AWS from data visualization company Tableau Software.

Keep Reading Show less
Donna Goodison

Donna Goodison (@dgoodison) is Protocol's senior reporter focusing on enterprise infrastructure technology, from the 'Big 3' cloud computing providers to data centers. She previously covered the public cloud at CRN after 15 years as a business reporter for the Boston Herald. Based in Massachusetts, she also has worked as a Boston Globe freelancer, business reporter at the Boston Business Journal and real estate reporter at Banker & Tradesman after toiling at weekly newspapers.

Image: Protocol

We launched Protocol in February 2020 to cover the evolving power center of tech. It is with deep sadness that just under three years later, we are winding down the publication.

As of today, we will not publish any more stories. All of our newsletters, apart from our flagship, Source Code, will no longer be sent. Source Code will be published and sent for the next few weeks, but it will also close down in December.

Keep Reading Show less
Bennett Richardson

Bennett Richardson ( @bennettrich) is the president of Protocol. Prior to joining Protocol in 2019, Bennett was executive director of global strategic partnerships at POLITICO, where he led strategic growth efforts including POLITICO's European expansion in Brussels and POLITICO's creative agency POLITICO Focus during his six years with the company. Prior to POLITICO, Bennett was co-founder and CMO of Hinge, the mobile dating company recently acquired by Match Group. Bennett began his career in digital and social brand marketing working with major brands across tech, energy, and health care at leading marketing and communications agencies including Edelman and GMMB. Bennett is originally from Portland, Maine, and received his bachelor's degree from Colgate University.

Enterprise

Why large enterprises struggle to find suitable platforms for MLops

As companies expand their use of AI beyond running just a few machine learning models, and as larger enterprises go from deploying hundreds of models to thousands and even millions of models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

As companies expand their use of AI beyond running just a few machine learning models, ML practitioners say that they have yet to find what they need from prepackaged MLops systems.

Photo: artpartner-images via Getty Images

On any given day, Lily AI runs hundreds of machine learning models using computer vision and natural language processing that are customized for its retail and ecommerce clients to make website product recommendations, forecast demand, and plan merchandising. But this spring when the company was in the market for a machine learning operations platform to manage its expanding model roster, it wasn’t easy to find a suitable off-the-shelf system that could handle such a large number of models in deployment while also meeting other criteria.

Some MLops platforms are not well-suited for maintaining even more than 10 machine learning models when it comes to keeping track of data, navigating their user interfaces, or reporting capabilities, Matthew Nokleby, machine learning manager for Lily AI’s product intelligence team, told Protocol earlier this year. “The duct tape starts to show,” he said.

Keep Reading Show less
Kate Kaye

Kate Kaye is an award-winning multimedia reporter digging deep and telling print, digital and audio stories. She covers AI and data for Protocol. Her reporting on AI and tech ethics issues has been published in OneZero, Fast Company, MIT Technology Review, CityLab, Ad Age and Digiday and heard on NPR. Kate is the creator of RedTailMedia.org and is the author of "Campaign '08: A Turning Point for Digital Media," a book about how the 2008 presidential campaigns used digital media and data.

Latest Stories
Bulletins